Filed 15d ago· May 19, 2026
40 days to disclose
Josh Gottheimer
DHouseNew Jersey-05
↓sold
Ally Financial
ALLY
$1K-$15K
+1.0% vs S&P 500
Trade dateApr 9, 2026
⚑ Banking
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.




































































































| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
May 19, 2026 15d ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Ally Financial ALLY ⚑ Banking · Financial Services | Apr 9, 2026 40 days to disclose | Flat·+0.0% +1.0% vs S&P 500 | $1K-$15K midpoint $8K |
May 13, 2026 21d ago | ![]() Byron Donalds RHouseFlorida-19 | ↑bought | Eli Lilly LLY SP Eli Lilly and Company | Apr 2, 2026 41 days to disclose | Good buy·+$1K+12.8% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
May 13, 2026 21d ago | ![]() Byron Donalds RHouseFlorida-19 | ↑bought | Eli Lilly LLY | Apr 2, 2026 41 days to disclose | Good buy·+$1K+12.8% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
May 8, 2026 26d ago | ![]() Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Eli Lilly LLY | Apr 14, 2026 24 days to disclose | Good buy·+$1.2K+14.4% +14.6% vs S&P 500 | $1K-$15K midpoint $8K |
May 1, 2026 1mo ago | ![]() Lizzie Fletcher DHouseTexas-07 | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Energy and Commerce | Apr 8, 2026 23 days to disclose | Flat·+0.0% −0.8% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 7, 2026 1mo ago | ![]() Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Eli Lilly LLY | Mar 13, 2026 25 days to disclose | Flat·+0.0% −0.9% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 24, 2026 2mo ago | ![]() Angus S., Jr. King ISenateMaine | ↓sold | Eli Lilly LLY | Feb 13, 2026 39 days to disclose | Flat·+0.0% −5.8% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 6, 2026 2mo ago | ![]() David J. Taylor RHouseOhio-02 | ↑bought | Eli Lilly LLY | Feb 26, 2026 8 days to disclose | Good buy·+$262+3.3% +8.9% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 20, 2026 3mo ago | ![]() David J. Taylor RHouseOhio-02 | ↓sold | Eli Lilly LLY | Feb 9, 2026 11 days to disclose | Flat·+0.0% −5.0% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 2, 2026 4mo ago | ![]() David J. Taylor RHouseOhio-02 | ↓sold | Eli Lilly LLY | Jan 16, 2026 17 days to disclose | Flat·+0.0% −4.6% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 26, 2026 4mo ago | ![]() Angus S., Jr. King ISenateMaine | ↑bought | Eli Lilly LLY | Dec 29, 2025 28 days to disclose | Bad buy·−$67-0.8% +3.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 20, 2026 4mo ago | ![]() August Pfluger RHouseTexas-11 | ↔exchanged | Liberty Live Holdings LLYVK Liberty Live ⚑ Telecom · Energy and Commerce | Dec 16, 2025 35 days to disclose | price pending | $1K-$15K midpoint $8K |
Jan 16, 2026 4mo ago | ![]() Markwayne Mullin RSenateOklahoma | ↑bought | Eli Lilly LLY | Dec 29, 2025 18 days to disclose | Bad buy·−$701-2.2% +2.5% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jan 16, 2026 4mo ago | ![]() Thomas H. Kean Jr. RHouseNew Jersey-07 | ↔exchanged | Liberty Live Holdings LLYVA Liberty Live ⚑ Telecom · Energy and Commerce | Dec 16, 2025 31 days to disclose | price pending | $1K-$15K midpoint $8K |
Jan 16, 2026 4mo ago | ![]() Thomas H. Kean Jr. RHouseNew Jersey-07 | ↔exchanged | Liberty Live Holdings LLYVK Liberty Live ⚑ Telecom · Energy and Commerce | Dec 16, 2025 31 days to disclose | price pending | $1K-$15K midpoint $8K |
Jan 15, 2026 4mo ago | ![]() Julie Johnson DHouseTexas-32 | ↓sold | Eli Lilly LLY | Dec 18, 2025 28 days to disclose | Flat·+0.0% −3.5% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 19, 2025 5mo ago | ![]() David J. Taylor RHouseOhio-02 | ↓sold | Eli Lilly LLY | Dec 10, 2025 9 days to disclose | Flat·+0.0% −2.4% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 15, 2025 5mo ago | ![]() Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Eli Lilly LLY | Nov 18, 2025 27 days to disclose | Good buy·+$197+2.5% +5.1% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 11, 2025 5mo ago | ![]() Julie Johnson DHouseTexas-32 | ↓sold | Eli Lilly LLY | Nov 13, 2025 28 days to disclose | Flat·+0.0% −2.8% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 8, 2025 5mo ago | ![]() John Boozman RSenateArkansas | ↓sold | Eli Lilly LLY | Nov 21, 2025 17 days to disclose | Flat·+0.0% −3.9% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 4, 2025 7mo ago | ![]() Shelley Moore Capito RSenateWest Virginia | ↑bought | Eli Lilly LLY ⚑ Pharmaceutical · Commerce, Science, and Transportation | Oct 24, 2025 11 days to disclose | Good buy·+$2.2K+27.9% +26.2% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2025 7mo ago | ![]() Val T. Hoyle DHouseOregon-04 | ↓sold | Eli Lilly LLY | Sep 23, 2025 17 days to disclose | Flat·+0.0% +8.4% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | ![]() John Boozman RSenateArkansas | ↑bought | Eli Lilly LLY | Aug 22, 2025 21 days to disclose | Good buy·+$3.9K+48.3% +40.8% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | ![]() John Boozman RSenateArkansas | ↑bought | Eli Lilly LLY | Aug 11, 2025 32 days to disclose | Good buy·+$5.3K+66.2% +52.2% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | ![]() Val T. Hoyle DHouseOregon-04 | ↓sold | Eli Lilly LLY | May 6, 2025 129 days to disclose · 84 past 45-day window | Flat·+0.0% +10.6% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | ![]() Val T. Hoyle DHouseOregon-04 | ↑bought | Eli Lilly LLY | Oct 29, 2024 318 days to disclose · 273 past 45-day window | Good buy·+$2.6K+32.4% +32.3% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 11, 2025 8mo ago | ![]() Julie Johnson DHouseTexas-32 | ↓sold | Eli Lilly LLY | Aug 14, 2025 28 days to disclose | Flat·+0.0% +10.9% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 2, 2025 9mo ago | ![]() David J. Taylor RHouseOhio-02 | ↑bought | Eli Lilly LLY | Aug 14, 2025 19 days to disclose | Good buy·+$4.3K+54.2% +43.4% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 2, 2025 9mo ago | ![]() David J. Taylor RHouseOhio-02 | ↑bought | Eli Lilly LLY | Aug 14, 2025 19 days to disclose | Good buy·+$17.6K+54.2% +43.4% vs S&P 500 | $15K-$50K midpoint $32.5K |
Aug 25, 2025 9mo ago | ![]() Jonathan L. Jackson DHouseIllinois-01 | ↓sold | Eli Lilly LLY | May 21, 2025 96 days to disclose · 51 past 45-day window | Flat·+0.0% +12.9% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 25, 2025 9mo ago | ![]() Jonathan L. Jackson DHouseIllinois-01 | ↑bought | Eli Lilly LLY | Apr 23, 2025 124 days to disclose · 79 past 45-day window | Good buy·+$2.3K+29.0% +19.6% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | ![]() Lisa C. McClain RHouseMichigan-09 | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jul 16, 2025 28 days to disclose | Flat·+0.0% +10.6% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | ![]() Lisa C. McClain RHouseMichigan-09 | ↑bought | Eli Lilly LLY ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jul 10, 2025 34 days to disclose | Good buy·+$2.8K+35.3% +26.3% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | ![]() Lisa C. McClain RHouseMichigan-09 | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jun 9, 2025 65 days to disclose · 20 past 45-day window | Flat·+0.0% +10.7% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | ![]() Lisa C. McClain RHouseMichigan-09 | ↑bought | Eli Lilly LLY ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Dec 11, 2024 245 days to disclose · 200 past 45-day window | Good buy·+$2.8K+34.4% +29.9% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 12, 2025 9mo ago | ![]() Markwayne Mullin RSenateOklahoma | ↑bought | Eli Lilly LLY | Dec 11, 2024 244 days to disclose · 199 past 45-day window | Good buy·+$24.4K+32.6% +28.1% vs S&P 500 | $50K-$100K midpoint $75K |
Jul 23, 2025 10mo ago | ![]() August Pfluger RHouseTexas-11 | ↓sold | Liberty Live Holdings LLYVK Liberty Live ⚑ Telecom · Energy and Commerce | Jul 1, 2025 22 days to disclose | Flat·+0.0% +7.2% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 14, 2025 10mo ago | ![]() Jonathan L. Jackson DHouseIllinois-01 | ↓sold | Eli Lilly LLY | Jun 3, 2025 41 days to disclose | Flat·+0.0% +11.6% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jun 22, 2025 11mo ago | ![]() Jefferson Shreve RHouseIndiana-06 | ↓sold | Eli Lilly LLY | May 12, 2025 41 days to disclose | Flat·+0.0% +9.2% vs S&P 500 | $100K-$250K midpoint $175K |
Jun 11, 2025 11mo ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | May 13, 2025 29 days to disclose | Flat·+0.0% +12.6% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 11, 2025 11mo ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Eli Lilly LLY | May 1, 2025 41 days to disclose | Good buy·+$2.8K+34.7% +26.0% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 6, 2025 12mo ago | ![]() Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Eli Lilly LLY | May 30, 2025 7 days to disclose | Flat·+0.0% +12.0% vs S&P 500 | $1K-$15K midpoint $8K |
May 19, 2025 1.0y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Eli Lilly LLY | May 14, 2025 5 days to disclose | Good buy·+$4K+49.5% +34.2% vs S&P 500 | $1K-$15K midpoint $8K |
May 16, 2025 1.0y ago | ![]() Dan Newhouse RHouseWashington-04 | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Conservation, Research, and Biotechnology | Apr 11, 2025 35 days to disclose | Flat·+0.0% +8.5% vs S&P 500 | $1K-$15K midpoint $8K |
May 15, 2025 1.1y ago | ![]() Tommy Tuberville RSenateAlabama | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Apr 15, 2025 30 days to disclose | Flat·+0.0% +7.9% vs S&P 500 | $15K-$50K midpoint $32.5K |
May 14, 2025 1.1y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Apr 9, 2025 35 days to disclose | Flat·+0.0% +7.0% vs S&P 500 | $1K-$15K midpoint $8K |
May 14, 2025 1.1y ago | ![]() Julie Johnson DHouseTexas-32 | ↓sold | Eli Lilly LLY | Apr 7, 2025 37 days to disclose | Flat·+0.0% +10.4% vs S&P 500 | $1K-$15K midpoint $8K |
May 13, 2025 1.1y ago | ![]() Jonathan L. Jackson DHouseIllinois-01 | ↑bought | Eli Lilly LLY | Apr 21, 2025 22 days to disclose | Good buy·+$10K+30.8% +18.7% vs S&P 500 | $15K-$50K midpoint $32.5K |
May 12, 2025 1.1y ago | ![]() Bruce Westerman RHouseArkansas-04 | ↓sold | Eli Lilly LLY | Apr 21, 2025 21 days to disclose | Flat·+0.0% +12.0% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Eli Lilly LLY | May 5, 2025 1 day to disclose | Good buy·+$2.4K+30.2% +22.7% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 28, 2025 1.1y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Conservation, Research, and Biotechnology | Apr 8, 2025 20 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 16, 2025 1.1y ago | ![]() Bruce Westerman RHouseArkansas-04 | ↑bought | Eli Lilly LLY | Mar 3, 2025 44 days to disclose | Good buy·+$1.1K+13.5% +14.2% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 10, 2025 1.1y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Mar 10, 2025 31 days to disclose | Flat·+0.0% +0.6% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 6, 2025 1.2y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Feb 19, 2025 15 days to disclose | Flat·+0.0% +1.4% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 21, 2025 1.3y ago | ![]() Ron Wyden DSenateOregon | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Finance | Feb 10, 2025 11 days to disclose | Flat·+0.0% +1.5% vs S&P 500 | $50K-$100K midpoint $75K |
Feb 21, 2025 1.3y ago | ![]() Ron Wyden DSenateOregon | ↑bought | Eli Lilly LLY ⚑ Pharmaceutical · Finance | Jan 22, 2025 30 days to disclose | Good buy·+$31.4K+41.9% +37.4% vs S&P 500 | $50K-$100K midpoint $75K |
Feb 10, 2025 1.3y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Jan 8, 2025 33 days to disclose | Flat·+0.0% +5.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 27, 2025 1.3y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Eli Lilly LLY | Jan 21, 2025 6 days to disclose | Good buy·+$3.5K+44.1% +39.9% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 14, 2025 1.4y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Dec 18, 2024 27 days to disclose | Flat·+0.0% +8.1% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 14, 2025 1.4y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Dec 16, 2024 29 days to disclose | Flat·+0.0% +6.6% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 14, 2025 1.4y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Dec 13, 2024 32 days to disclose | Flat·+0.0% +5.3% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 14, 2025 1.4y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Dec 12, 2024 33 days to disclose | Flat·+0.0% +5.3% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 14, 2025 1.4y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Dec 11, 2024 34 days to disclose | Flat·+0.0% +4.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 14, 2025 1.4y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Dec 10, 2024 35 days to disclose | Flat·+0.0% +3.1% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 14, 2025 1.4y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Dec 9, 2024 36 days to disclose | Flat·+0.0% +2.6% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 27, 2024 1.4y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Eli Lilly LLY | Dec 24, 2024 3 days to disclose | Good buy·+$2.8K+34.4% +27.8% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 12, 2024 1.5y ago | ![]() Greg Landsman DHouseOhio-01 | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Energy and Commerce | Nov 8, 2024 34 days to disclose | Flat·+0.0% −1.1% vs S&P 500 | $15K-$50K midpoint $32.5K |
Dec 5, 2024 1.5y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Nov 19, 2024 16 days to disclose | Flat·+0.0% +5.2% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 5, 2024 1.5y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Nov 14, 2024 21 days to disclose | Flat·+0.0% +2.8% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 7, 2024 1.6y ago | ![]() Sheldon Whitehouse DSenateRhode Island | ↑bought | Eli Lilly LLY ⚑ Pharmaceutical · Commerce, Science, and Transportation | Oct 30, 2024 8 days to disclose | Good buy·+$11.1K+34.1% +33.9% vs S&P 500 | $15K-$50K midpoint $32.5K |
Nov 6, 2024 1.6y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Oct 16, 2024 21 days to disclose | Flat·+0.0% −3.1% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 21, 2024 1.8y ago | ![]() Jared Moskowitz DHouseFlorida-23 | ↑bought | Eli Lilly LLY | Dec 28, 2023 237 days to disclose · 192 past 45-day window | Good buy·+$6.7K+84.2% +75.2% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 21, 2024 1.8y ago | ![]() Jared Moskowitz DHouseFlorida-23 | ↑bought | Eli Lilly LLY | Sep 1, 2023 355 days to disclose · 310 past 45-day window | Good buy·+$7.4K+92.0% +80.8% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 15, 2024 1.8y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Jul 1, 2024 45 days to disclose | Flat·+0.0% +2.5% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 14, 2024 1.8y ago | ![]() Greg Landsman DHouseOhio-01 | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Energy and Commerce | Jun 3, 2024 72 days to disclose · 27 past 45-day window | Missed gain·−$507-6.3% +28.9% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 14, 2024 1.8y ago | ![]() Greg Landsman DHouseOhio-01 | ↑bought | Eli Lilly LLY ⚑ Pharmaceutical · Energy and Commerce | May 11, 2023 461 days to disclose · 416 past 45-day window | Good buy·+$11.4K+142.3% +130.1% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 14, 2024 1.8y ago | ![]() Greg Landsman DHouseOhio-01 | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Energy and Commerce | Feb 2, 2023 559 days to disclose · 514 past 45-day window | Flat·+0.0% +11.6% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 14, 2024 1.8y ago | ![]() Greg Landsman DHouseOhio-01 | ↑bought | Eli Lilly LLY ⚑ Pharmaceutical · Energy and Commerce | Jan 18, 2023 574 days to disclose · 529 past 45-day window | Good buy·+$16K+199.8% +188.1% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 12, 2024 2.0y ago | ![]() Roger Williams RHouseTexas-25 | ↑bought | Eli Lilly LLY | Jun 30, 2022 713 days to disclose · 668 past 45-day window | Good buy·+$13.8K+172.6% +83.4% vs S&P 500 | $1K-$15K midpoint $8K |
May 15, 2024 2.1y ago | ![]() Tommy Tuberville RSenateAlabama | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Apr 3, 2024 42 days to disclose | Missed gain·−$4.5K-13.9% +23.5% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 25, 2024 2.1y ago | ![]() Dan Newhouse RHouseWashington-04 | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Conservation, Research, and Biotechnology | Apr 10, 2024 15 days to disclose | Missed gain·−$1.3K-16.0% +22.9% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 7, 2024 2.2y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Feb 8, 2024 28 days to disclose | Flat·+0.0% +3.0% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 14, 2024 2.3y ago | ![]() Tommy Tuberville RSenateAlabama | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Jan 3, 2024 42 days to disclose | Flat·+0.0% +7.2% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jan 22, 2024 2.4y ago | ![]() Jared Moskowitz DHouseFlorida-23 | ↓sold | Eli Lilly LLY | Dec 28, 2023 25 days to disclose | Flat·+0.0% +9.0% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 18, 2024 2.4y ago | ![]() Sheldon Whitehouse DSenateRhode Island | ↑bought | Eli Lilly LLY ⚑ Pharmaceutical · Commerce, Science, and Transportation | Dec 14, 2023 35 days to disclose | Good buy·+$4.3K+54.1% +2.8% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 8, 2023 2.5y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Eli Lilly LLY | Nov 16, 2023 22 days to disclose | Good buy·+$6.5K+81.7% +66.1% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 8, 2023 2.5y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Nov 13, 2023 25 days to disclose | Flat·+0.0% +16.9% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 11, 2023 2.6y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Eli Lilly LLY | Oct 16, 2023 26 days to disclose | Good buy·+$5.9K+73.5% +60.2% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 1, 2023 2.6y ago | ![]() Markwayne Mullin RSenateOklahoma | ↑bought | Eli Lilly LLY | Oct 3, 2023 29 days to disclose | Good buy·+$5.5K+68.3% −1.0% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 17, 2023 2.6y ago | ![]() Sheldon Whitehouse DSenateRhode Island | ↑bought | Eli Lilly LLY ⚑ Pharmaceutical · Commerce, Science, and Transportation | Sep 20, 2023 27 days to disclose | Good buy·+$17.9K+55.2% −7.6% vs S&P 500 | $15K-$50K midpoint $32.5K |
Oct 15, 2023 2.6y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Eli Lilly LLY | Sep 12, 2023 33 days to disclose | Good buy·+$6.3K+78.5% +66.7% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 13, 2023 2.6y ago | ![]() Tommy Tuberville RSenateAlabama | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Sep 8, 2023 35 days to disclose | Flat·+0.0% +12.5% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 12, 2023 2.6y ago | ![]() Markwayne Mullin RSenateOklahoma | ↑bought | Eli Lilly LLY | Sep 13, 2023 29 days to disclose | Good buy·+$15.5K+47.6% −12.3% vs S&P 500 | $15K-$50K midpoint $32.5K |
Oct 4, 2023 2.7y ago | ![]() John R. Curtis RSenateUtah | ↑bought | Eli Lilly LLY ⚑ Pharmaceutical · Commerce, Science, and Transportation | Sep 13, 2023 21 days to disclose | Good buy·+$3.8K+47.6% −12.3% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 16, 2023 2.7y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | Aug 22, 2023 25 days to disclose | Flat·+0.0% +11.5% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 15, 2023 2.7y ago | ![]() Thomas H. Kean Jr. RHouseNew Jersey-07 | ↔exchanged | Liberty Live Holdings LLYVA Liberty Live ⚑ Telecom · Energy and Commerce | Aug 4, 2023 42 days to disclose | price pending | $1K-$15K midpoint $8K |
Sep 15, 2023 2.7y ago | ![]() Thomas H. Kean Jr. RHouseNew Jersey-07 | ↔exchanged | Liberty Live Holdings LLYVK Liberty Live ⚑ Telecom · Energy and Commerce | Aug 4, 2023 42 days to disclose | price pending | $1K-$15K midpoint $8K |
Aug 13, 2023 2.8y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↓sold | Csl Ltd. CSLLY Csl Ltd SPONSORED ADR | Jul 10, 2023 34 days to disclose | Flat·+0.0% +70.7% vs S&P 500 | $50K-$100K midpoint $75K |
Jun 11, 2023 3.0y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Eli Lilly LLY | May 9, 2023 33 days to disclose | Good buy·+$12K+149.7% +137.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 11, 2023 3.0y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Eli Lilly LLY | May 8, 2023 34 days to disclose | Flat·+0.0% +11.4% vs S&P 500 | $1K-$15K midpoint $8K |